key: cord-0333676-xp3uaset
authors: Lu, J. H.; Callahan, A.; Patel, B.; Morse, K.; Dash, D.; Shah, N.
title: Low adherence to existing model reporting guidelines by commonly used clinical prediction models
date: 2021-07-23
journal: nan
DOI: 10.1101/2021.07.21.21260282
sha: 96131b2324c98b3ac88b76d7d5662b060b7dc22b
doc_id: 333676
cord_uid: xp3uaset

Objective: To assess whether the documentation available for commonly used machine learning models developed by an electronic health record (EHR) vendor provides information requested by model reporting guidelines. Materials and Methods: We identified items requested for reporting from model reporting guidelines published in computer science, biomedical informatics, and clinical journals, and merged similar items into representative "atoms". Four independent reviewers and one adjudicator assessed the degree to which model documentation for 12 models developed by Epic Systems reported the details requested in each atom. We present summary statistics of consensus, interrater agreement, and reporting rates of all atoms for the 12 models. Results: We identified 220 unique atoms across 15 model reporting guidelines. After examining the documentation for the 12 most commonly used Epic models, the independent reviewers had an interrater agreement of 76%. After adjudication, the model documentations' median completion rate of applicable atoms was 39% (range: 31%-47%). Most of the commonly requested atoms had reporting rates of 90% or above, including atoms concerning outcome definition, preprocessing, AUROC, internal validation and intended clinical use. For individual reporting guidelines, the median adherence rate for an entire guideline was 54% (range: 15%-71%). Atoms reported half the time or less included those relating to fairness (summary statistics and subgroup analyses, including for age, race/ethnicity, or sex), usefulness (net benefit, prediction time, warnings on out-of-scope use and when to stop use), and transparency (model coefficients). Atoms reported the least often related to missingness (missing data statistics, missingness strategy), validation (calibration plot, external validation), and monitoring (how models are updated/tuned, prediction monitoring). Conclusion: There are many recommendations about what should be reported about predictive models used to guide care. Existing model documentation examined in this study provides less than half of applicable atoms, and entire reporting guidelines have low adherence rates. Half or less of the reviewed documentation reported information related to usefulness, reliability, transparency and fairness of models. There is a need for better operationalization of reporting recommendations for predictive models in healthcare.

We identified 220 unique atoms across 15 model reporting guidelines. After examining the documentation for the 12 most commonly used Epic models, the independent reviewers had an interrater agreement of 76%. After adjudication, the model documentations' median completion rate of applicable atoms was 39% (range: 31%-47%). Most of the commonly requested atoms had reporting rates of 90% or above, including atoms concerning outcome definition, preprocessing, AUROC, internal validation and intended clinical use. For individual reporting guidelines, the median adherence rate for an entire guideline was 54% (range: 15%-71%). Atoms reported half the time or less included those relating to fairness (summary statistics and subgroup analyses, including for age, race/ethnicity, or sex), usefulness (net benefit, prediction time, warnings on out-of-scope use and when to stop use), and transparency (model coefficients).

Atoms relating to reliability also had low reporting, including those related to missingness (missing data statistics, missingness strategy), validation (calibration plot, external validation), and monitoring (how models are updated/tuned, prediction monitoring).

There are many recommendations about what should be reported about predictive models used to guide care. Existing model documentation examined in this study provides less than half of applicable atoms, and entire reporting guidelines have low adherence rates. Half or less of the reviewed documentation reported information related to usefulness, reliability, transparency and fairness of models. There is a need for better operationalization of reporting recommendations for predictive models in healthcare.

Despite good predictive performance in metrics such as the area under the receiver operating characteristic (AUROC) curve, the use of machine learning models trained on electronic health records (EHR) data 1 to guide care does not always translate into clinical gains in the form of better medical care, lower cost or more equitable outcomes, [2] [3] [4] leading to a gap referred to as an "Artificial Intelligence (AI) chasm". 5 Some potential causes of this chasm are that current models are not useful, 4,6,7 reliable, 8, 9 or fair. 10-18 Nevertheless, predictive models have been deployed in healthcare settings without transparency or independent validation, 19, 20 and their subsequent failures have been met with public outcry. 2, [21] [22] [23] Adhering to model reporting guidelines is one way to improve the usefulness, [24] [25] [26] [27] [28] fairness, 29, 30 and reliability 27, [31] [32] [33] [34] of clinical predictive models. Reporting guidelines have long been used to assess the strength of clinical trial studies, 35, 36 observational studies, 37 and diagnostic studies. 38 Guidelines concerning predictive models are receiving increasing attention, including from the National Institutes of Health, 39 and several more are in development. [40] [41] [42] While there has been increasing interest in model reporting guidelines, the degree to which currently deployed models adhere to these guidelines has not been studied. One review examining 164 models described in the scientific literature found low reporting rates of demographic variables such as race (36%) and socioeconomic status (8%) as well as low external validation rates (12%). 43 A critical review of published models for diagnosis and prognosis of COVID-19 found that most models were at high risk of bias due to poor reporting. 44 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The purpose of this analysis is to assess whether the documentation available for commonly deployed models provides the information requested by model reporting guidelines. Compared to previous work, 43, 44 we focus on user-facing product documentation accompanying models. Thus, we are able to analyze models that have been deployed in practice but not yet described in peerreviewed publications. Furthermore, we make a comprehensive assessment of the reporting rates of every requested item in the guidelines.

We searched MEDLINE via PubMed using queries for "machine learning model card" and "reporting machine learning" in November 2020. We reviewed citations to find additional publications. Finally, we excluded publications that did not give specific model reporting recommendations. We included all Explanation and Elaboration documents, AI-specific extensions and multi-part guidelines for papers which had them.

We gathered the set of reportable items in these reporting guidelines and deduplicated these items; i.e. we merged similar items into distinct, representative "atoms." For example, "report the intended user of the model" 24 or "describe external validation strategy" 31 are unique atoms. We performed the de-duplication in two rounds. First, we created an initial set of atoms by reviewing each reporting guideline, including the Explanation & Elaboration documents and AI-extensions to verify that every publication's atoms were captured. Second, we reviewed each atom and merged those that requested the same information. We recorded the phrases describing the atoms to enable a full traceback of which items were merged to the same atom. Lastly, we created a one-line summary of each atom to share in our reported results. To facilitate summarization, we . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 23, 2021. ; Four reviewers read each of the 12 Model Briefs and assessed whether they reported information specified in the atoms (eMethods). Specifically, for each atom, each reviewer first determined if the atom was applicable to the model. For example, an atom such as "A link to the clinical trial registration" is not applicable to models where documentation does not intend to describe a clinical trial. When atoms were applicable, the reviewer decided whether the Model Brief reported the information requested in the atom.

Atoms had consensus when all four reviewers agreed that an atom was reported by the Model Brief, was not reported by the Model Brief, or was determined to be not applicable. For atoms that did not have consensus across all four reviewers, a designated adjudicator reviewed the atoms and the corresponding Model Brief content, to independently adjudicate the reviewer responses.

To determine the inter-rater agreement, we calculated the fraction of atoms that a pair of reviewers agreed were reported, were not reported, or were determined to be not applicable, averaged across all Model Briefs and pairs of the four reviewers.

To standardize nomenclature, we define that an atom is "requested" by a reporting guideline if any reportable item from the reporting guideline was merged into that atom. We define that an atom is "reported" by a Model Brief if we determine that the Model Brief contained the information requested in the atom, after adjudication.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 23, 2021. ;

An atom's reporting rate is the number of Model Briefs that reported the atom divided by the number of Model Briefs for which the atom was applicable. A Model Brief's completion rate of a given group of atoms is the number of atoms reported by the Model Brief divided by the number of atoms that were applicable to that Model Brief. Finally, the adherence rate to a reporting guideline is the completion rate of atoms requested by the specific reporting guideline, averaged across all Model Briefs. We calculate median, interquartile range (IQR) and range for atoms' reporting rates, Model Briefs' completion rates, and reporting guidelines' adherence rates, as appropriate.

Our MEDLINE search resulted in an initial list of 26 publications. [24] [25] [26] [27] [28] [29] [30] 38, 41, [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] We reviewed citations and found 3 additional publications. [32] [33] [34] We excluded publications that did not give specific model reporting recommendations to arrive at our final list of 15 model reporting guidelines published (Table 1) . [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] 38, [45] [46] [47] [62] [63] [64] [65] Publication venues include computer science venues (ACM Fairness, Accountability, and is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 23, 2021. ; published between 2010 and 2015 have been cited by other articles over 1000 times to date, while four guidelines were published after 2019 and have been cited less than 50 times to date.

Of the 15 reporting guidelines, 11 had examples of how to complete their requested atoms. 24, 27, 29, 30, 32, 33, 38, [62] [63] [64] [65] However, only 5 showed a full example completing all atoms for a single model, 24, 29, 30, 33, 62 and only 1 of those models was deployed in a health system. 24, 66 After deduplication, there were 220 distinct atoms requested by all of the reporting guidelines (eFile 1). We provide a cross tabulation of the 220 atoms against the 15 reporting guidelines (eTable 1) to show the most relevant guideline for a task. For example, the TRIPOD reporting guideline has more atoms requesting details on preprocessing 47 while MI-CLAIM has more atoms requesting details for model examinations. 46 There are stages in the creation and evaluation of a machine learning model for which reporting guidelines focus less; for example, there are less than five atoms related to Deployment Design, e.g.. considering work capacity and resources to perform interventions, and for Utility . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 23, 2021. ;

Assessment, e.g. considering the net benefit of taking actions guided by the model's output.

Meanwhile, the Model Development step comprises 53 atoms. Table 2 shows the atoms requested by at least 10 out of the 15 reporting guidelines. The most commonly requested atoms relate to model development tasks, such as preprocessing, missing data handling, model performance including handling of uncertainty (e.g. confidence intervals, statistical significance) or AUROC, and internal validation. A total of 28 distinct performance metrics were requested (eTable 2), including discrimination, calibration, classification, goodness-of-fit, utility, and comparisons of model discrimination.

Finally, there were 77 atoms that were requested by just one reporting guideline (eTable 3). ML Test Score had 20 unique atoms related to model deployment and monitoring, such as steps for model updating and rollback. CONSORT-AI and SPIRIT-AI had a combined 21 clinical trialspecific atoms, which mostly did not apply to Epic's Model Briefs (e.g. random allocation methods). Twelve uniquely requested atoms were model performance metrics such as the F-Score or Relative Utility.

A median of 93 (IQR: 88-95, range: 66-108) atoms per brief underwent adjudication for discordant findings by reviewers. Interrater agreement on atom reporting was 76%.

There were 40 commonly reported atoms, whose information was reported by over 90% of the Model Briefs (eTable 4). These atoms requested information about model development and . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 23, 2021. ; formulation, including the training data set, preprocessing, model type, internal validation, and performance metrics. These 40 commonly reported atoms by Model Briefs included 9 of the 12 most commonly requested atoms across the reporting guidelines (Table 2) .

There were 75 rarely reported atoms, whose information was reported in less than 10% of the Model Briefs (eTable 5). These atoms included missing data statistics, blinding of predictor/outcome assessors, variability of performance measures (e.g. confidence intervals), is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 23, 2021. ; atoms was 39% (IQR: 37%-43%, range: 31%-47%). After excluding all atoms corresponding to performance metrics --to ensure briefs were not penalized for not reporting multiple redundant performance metrics --the median completion rate for applicable atoms was 43% (IQR: 41%-48%, range: 33%-52%). Lastly, every Model Brief covered the following use case-related atoms:

how the model is to be used in clinical care, who will use the model, ways the model could impact clinical care, and rationale for use. Table 3 shows the adherence rates to individual reporting guidelines, which is the Model Briefs' average completion rate of atoms requested by the reporting guideline. Model reporting guidelines had a median adherence rate of 53% (IQR: 50%-63%, range: 18%-74%). The ML Test Score had the lowest adherence rate (18%) while Model Facts Labels had the highest (74%).

After excluding redundant performance metrics as before, the median adherence rates remained similar, at 57% (IQR: 50%-70%, range: 16%-73%).

We identified 29 atoms that were requested by at least 4 out of 15 the reporting guidelines, but were reported by 50% or less of Model Briefs ( Table 4 ). Many of these less reported atoms are related to fairness, i.e. data set representativeness and performance across subgroups. These include summary statistics of key characteristics of the training data set (reporting rate 50%) or disaggregating performance by a subgroup (33%). Key factors such as age (50%), sex (33%), and other relevant factors (50%) lacked both summary statistics and disaggregated performance.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 23, 2021. ; There was low availability of information on missingness-related atoms, including statistics on amount of missing data (8.3%) and how missing data were handled (50%). There was low information on atoms related to interpreting the model and its performance, such as model coefficients (8.3%), confidence intervals or statistical significance in model performance metrics (0%), and performance of an external validation (33%). There was low reporting of guidance on how to deploy the ML model into a clinical workflow (33%), what user-facing materials there will be with the model (0%), and how models are updated (42%). Lastly, some logistical information had 0% completion, including who funded the study (which might be relevant for conflict of interest purposes) and how to access the data set.

This work is one of the first to systematically compile atoms from reporting guidelines and analyze deployed models' adherence to existing model reporting guidelines. The 220 atoms, compiled from 15 model reporting guidelines, demonstrate the breadth of details that model developers and researchers consider important to report about a model that will guide care. These atoms cover a range of steps in bringing a model into clinical use ( Figure 1 ). Some categories of model development and deployment have many corresponding atoms, while others have few. For example, while there are 28 atoms on model performance metrics, there are few related to deployment design such as work capacity and resources to perform interventions, 7 and utility assessment, including eliciting stakeholder preferences. 67 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 23, 2021. ;

Model Briefs had excellent reporting of the most commonly requested atoms ( Table 2 ): 9 of the 12 most commonly requested atoms had reporting rates above 90%. These included information on model development and use, such as the outcome definition, and how the model is intended to be used. However, Model Briefs had low completion rates of all applicable atoms (median 39%). We acknowledge that some reporting guidelines were published after some Model Briefs were created, so it may not be reasonable to expect Model Briefs to adhere fully to those reporting guidelines. Nevertheless, the low completion rate overall suggests that the combined request of all atoms may be formidable for model developers to report and adhere to. (Table 4) . Broadly, these relate to fairness, utility, reliability and transparency. For atoms relating to fairness (in this case, referring to data set representativeness and model performance for subgroups), there was low reporting of summary statistics or disaggregated performance for race/ethnicity (33%), age (50%), sex (33%), and other relevant . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 23, 2021. ; factors (50%). Subgroup and intersectional analyses were rarely performed (33%, 0%), despite evidence of algorithms' discriminatory behavior against individuals in subgroups 2 and intersectional subgroups. 68 We further acknowledge this is a limited view of "fairness" (which has an entire dedicated field of scholarship 69 ) and that atoms must be contextualized depending on how the model is used and how the data is collected. For example, biased outcome measurement would not be captured by subgroup analyses of performance. 6 For atoms relating to utility (referring to the net benefit of model use, including from the standpoint of stakeholder values and resource constraints 7,70-76 ), none of the Model Briefs reported any utility-related metrics, including the Net Benefit. 32, 33, 65 Work capacity 7 (resources required to perform interventions) or stakeholder preferences 67,77 were not formally requested by any model reporting guideline, nor reported by any Model Brief. This is despite studies showing that utility-maximizing models may be different from discrimination-maximizing models 78 and that work capacity must be taken into consideration for models to create net benefit for patients. 7 Finally, while there was 100% reporting of atoms on both the intended user and intended use of the model in a specific clinical context, more detailed information on deployment was often missing, like specific guidance on how to deploy into a workflow (33%), specific directions or other user-facing material (0%), time of model prediction (33%), and warnings on out-of-scope use (42%) and when to stop use (8.3%).

For atoms relating to reliability (referring to the stable performance of clinical predictive models across time and deployment sites), there was low reporting of atoms regarding missingness, validation, and monitoring. For missingness, missing data statistics and strategy of missingness . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 23, 2021. ;  handling had low reporting rates (8.3% and 50%). For validation, external validation strategy (33%), calibration plots (0%), and performance comparison against a baseline model (58%) also had low reporting. For monitoring, how models are updated and tuned had a low reporting rate of 42%, and other key atoms for monitoring had reporting rates less than 10%, such as monitoring input data (10%) or regressions in prediction quality in newer data (8.3%).

Lastly, on transparency, there was low reporting of information to enable model reproducibility (0%), model coefficients (8.3%), how to access the data set (0%) (acknowledging necessary limits to protect patient privacy), and who funded the study (0%), which might be relevant for conflict of interest purposes. Model Briefs are not accessible to those without an Epic institutional license, which may further hamper reproducibility and independent validation. A recent independent validation of the Epic Sepsis Model indeed found decreased calibration and discrimination. 23 Low adherence rates when considering entire model reporting guidelines suggest opportunities to better operationalize reporting practices to ensure deployed models are useful, reliable and fair.

One might choose among the many available reporting guidelines by tracking which models have reported atoms from which guideline. Such usage analysis would allow prioritization of more relevant and feasible reporting practices. Similarly, we could incentivise improved reporting if models that have better reporting result in higher adoption, perhaps via endorsement from professional societies in a manner similar to clinical practice guidelines. This could be enabled by a public dashboard tracking models' guideline adherence. Lastly, deployment teams can benefit from adherence to reporting guidelines by using the atoms from them as checklists for assessing usefulness, workflow capacity, reliability monitoring, 27 and reviewing them at project initiation time. 79 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 23, 2021. ; There are several key limitations of our methods. First of all, our deduplication of the reporting guidelines may mask certain differences --e.g. some guidelines provide explicit instructions and examples while others just call for reporting. We also caution against over-interpreting the completion rate across all atoms, as atoms are not exchangeable entities. Two atoms such as "Missing data statistics" and "Sensitivity" provide different information, so we recommend looking at individual atoms when possible. Lastly, to provide an upper bound on the quality of reporting, we gave generous credit to Model Briefs for reporting of an atom. For example, we gave credit for "Describe how models were tested in a new setting before deployment" for statements that might have simply stated to contact a support representative to validate the model. Hence reporting rates should be viewed as likely overestimates.

Despite ongoing discussion on what should be reported about predictive models, adherence of current documentation for deployed models to existing reporting guidelines has not been assessed. In this work, we compiled reportable items from existing reporting guidelines into a set of unique "atoms" and reviewed the documentation of the 12 most adopted models from a widely used health vendor, Epic. We identified 220 distinct atoms, of which 176 were applicable to at least one model. Current model documentation reports information for less than half of applicable atoms (median 39% per Model Brief), and model reporting guidelines have low adherence rates based on the . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 23, 2021. ; documentation (median 54% per guideline). Current model documentation provides relatively little information on usefulness, reliability, transparency and fairness. There is a need for better operationalization of reporting practices for predictive models in healthcare.

All data and code used for methods, including merging of guidelines, deduplication of atoms, . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 23, 2021. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 23, 2021. ; Table 1 : Summary of 15 Model reporting guideline papers. "Total citations" sums the citations for each of the papers, excluding the Explanation and Elaboration papers. "Atoms" indicates the number of deduplicated atoms sourced from that guideline. We included the Explanation and Elaboration papers for CONSORT, SPIRIT, TRIPOD and PROBAST [ 32, [63] [64] [65] . For CONSORT and SPIRIT, we also included the AI-specific extensions 25, 26 . We grouped Risk Prediction Models II 31 with the Risk Prediction Models I paper 62 .

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 23, 2021. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 23, 2021 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 23, 2021. 

Scalable and accurate deep learning with electronic health records

Dissecting racial bias in an algorithm used to manage the health of populations

Better medicine through machine learning: What's real, and what's artificial?

Artificial Intelligence in Health Care: Will the Value Match the Hype?

High-performance medicine: the convergence of human and artificial intelligence

Adoption of artificial intelligence and machine learning is increasing, but irrational exuberance remains

A framework for making predictive models useful in practice

Challenges to the Reproducibility of Machine Learning Models in Health Care

Artificial Intelligence in Health Care: A Report From the National Academy of Medicine

Predictably unequal: understanding and addressing concerns that algorithmic clinical prediction may increase health disparities

Ensuring Fairness in Machine Learning to Advance Health Equity

Addressing Bias in Artificial Intelligence in Health Care

Racial/Ethnic Disparities in the Performance of Prediction Models for Death by Suicide After Mental Health Visits

Comparison of Methods to Reduce Bias From Clinical Prediction Models of Postpartum Depression

CheXclusion: Fairness gaps in deep chest X-ray classifiers

Addressing bias in prediction models by improving subpopulation calibration

An empirical characterization of fair machine learning for clinical risk prediction

How a largely untested AI algorithm crept into hundreds of hospitals

How medical AI devices are evaluated: limitations and recommendations from an analysis of FDA approvals

A healthcare algorithm started cutting care, and no one knew why. The Verge

Popular sepsis prediction model works "substantially worse" than claimed, researchers find -MedCity News

External Validation of a Widely Implemented Proprietary Sepsis Prediction Model in Hospitalized Patients

Presenting machine learning model information to clinical end users with model facts labels

Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension

Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension

The ML test score: A rubric for ML production readiness and technical debt reduction

AI-enabled clinical decision support software: A "trust and value checklist" for clinicians

Model Cards for Model Reporting

MINIMAR (MINimum Information for Medical AI Reporting): Developing reporting standards for artificial intelligence in health care

Risk prediction models: II. External validation, model updating, and impact assessment

PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration

Towards better clinical prediction models: seven steps for development and an ABCD for validation

Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials

SPIRIT 2013: new guidance for content of clinical trial protocols. The Lancet

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

Artificial Intelligence Working Group Update. ACD Working Group on Artificial Intelligence: 119th Meeting of the Advisory Committee to the Director (ACD)

DECIDE-AI: new reporting guidelines to bridge the development-to-implementation gap in clinical artificial intelligence

Reporting of artificial intelligence prediction models

Developing specific reporting guidelines for diagnostic accuracy studies assessing AI interventions: The STARD-AI Steering Group

Reporting of demographic data and representativeness in machine learning models using electronic health records

Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal

Guidelines for Developing and Reporting Machine Learning Predictive Models in Biomedical Research: A Multidisciplinary View

Minimum information about clinical artificial intelligence modeling: the MI-CLAIM checklist

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD Statement

Overcoming barriers to the adoption and implementation of predictive modeling and machine learning in clinical care: what can we learn from US academic medical centers?

The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement

Veridical data science

Setting guidelines to report the use of AI in clinical trials

Assessing Quality of Surgical Real-World Data from an Automated Electronic Health Record Pipeline

Good intentions are not enough: how informatics interventions can worsen inequality

Data statements for natural language processing: Toward mitigating system bias and enabling better science

Datasheets for Datasets

Demystifying AI in healthcare

The Case for Algorithmic Stewardship for Artificial Intelligence and Machine Learning Technologies

Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies

Do no harm: a roadmap for responsible machine learning for health care

Evaluating artificial intelligence in medicine: phases of clinical research

Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker

Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration

Sepsis Watch: the implementation of a Duke-specific early warning system for sepsis

Gender Shades: Intersectional Accuracy Disparities in Commercial Gender Classification

Making Machine Learning Models Clinically Useful

Improving the efficiency of the operating room environment with an optimization and machine learning model

Optimization-based methods for operations scheduling

Reproducibility, and Agent-based Simulation of Interventions

Simulation Modeling of a Check-in and Medication Reconciliation Ambulatory Clinic Kiosk

Application of Constrained Optimization Methods in Health Services Research: Report 2 of the ISPOR Optimization Methods Emerging Good Practices Task Force

Constrained Optimization Methods in Health Services Research-An Introduction: Report 1 of the ISPOR Optimization Methods Emerging Good Practices Task Force. Value Health

Identifying Ethical Considerations for Machine Learning Healthcare Applications

Improving hospital readmission prediction using individualized utility analysis

A3 -institute for healthcare quality improvement

The authors would like to thank Scott Fleming, Siyun Li, Arjun Gokhale, Wui Ip, Lillian Sung, and Ron Li for providing project feedback and guidance, and members of the Shah lab and the Data Science Team at IAT for ideation, moral support, and feedback during a once-in-a-lifetime pandemic. Thanks to Stephen Pfohl for reader feedback.

None declared. Age is an important demographic factor to report summary statistics on or disaggregate performance by 50.0% 12 6 4 Sex is an important demographic factor to report summary statistics on or disaggregate performance by 33